Josh Neiman

Josh Neiman currently serves as the President and Chief Commercial Officer at Canopy since November 2024. Prior to this role, Neiman held the position of Chief Commercial Officer for North America and Europe at BeiGene from July 2018 to October 2024. Neiman's experience also includes serving as Vice President of Marketing at Flatiron Health and as Senior Director of US Market Access & Reimbursement and US Marketing for Kyprolis at Onyx Pharmaceuticals. Earlier roles include Group Product Manager for Rituxan and Clinical Oncology Specialist for Herceptin at Genentech, as well as roles at Plexxikon, Tao Biosciences, and Harris Lab. Neiman earned an MBA from Northwestern University's Kellogg School of Management and a BA in Molecular and Cell Biology from the University of California, Berkeley.